Form 4: Edgewell Officer's Stock Vesting and New Equity Grant

Edgewell Personal Care's Chief People & Legal Officer, LaTanya Langley, reported vesting of performance stock and acquisition of new restricted stock equivalents.

Summary

• LaTanya Langley, Chief People & Legal Officer of Edgewell Personal Care Co (EPC), reported equity transactions on November 13-14, 2025.
• On November 13, 2025, 5,773 shares of common stock vested from a performance stock award.
• Concurrently, 2,873 shares were withheld to cover tax liabilities at a price of $18.39 per share.
• The original performance stock award was for 16,353 shares, but only 5,773 vested due to performance criteria, resulting in 10,580 shares being cancelled.
• Following these transactions, direct beneficial ownership of common stock is 19,667 shares.
• On November 14, 2025, 24,270 Restricted Stock Equivalents (RSEs) were acquired.
• These RSEs will vest in three equal installments on November 14, 2026, 2027, and 2028, contingent on continued employment.

Sentiment

Score: 6

Explanation: The filing reports routine executive compensation transactions, including the vesting of performance stock and the grant of new restricted stock equivalents. While a significant portion of the performance award did not vest, the overall activity reflects ongoing incentive alignment.

Positives

• Vesting of 5,773 performance stock equivalents demonstrates achievement of performance criteria, albeit partially.
• Acquisition of 24,270 Restricted Stock Equivalents (RSEs) indicates continued long-term incentive and retention for the Chief People & Legal Officer.

Negatives

• Only 5,773 out of an original 16,353 performance stock award shares vested, meaning 10,580 shares were cancelled due to not meeting full performance criteria.

Risks

• Future vesting of Restricted Stock Equivalents is contingent on continued employment and other specific events (death, disability, change in control, certain termination events), posing a risk of forfeiture if conditions are not met.
• The partial vesting of the performance stock award (only 35% of the original grant) highlights the inherent risk in performance-based compensation tied to company metrics.

Future Outlook

The Chief People & Legal Officer is set to receive additional common stock through the vesting of 24,270 Restricted Stock Equivalents in three equal annual installments starting November 14, 2026, contingent on continued employment.

Industry Context

This Form 4 filing reflects standard executive compensation practices within publicly traded companies, involving performance-based equity awards and restricted stock equivalents designed to align executive incentives with long-term shareholder value and retention.

Comparison to Industry Standards

• The use of performance stock awards and restricted stock equivalents is a common practice in executive compensation across various industries, including consumer goods, to incentivize long-term performance and retention.
• The partial vesting of the performance award highlights the rigorous nature of performance targets, which is typical for well-governed companies.

Stakeholder Impact

• Shareholders: The vesting and grant of equity awards align executive incentives with shareholder interests, though the partial vesting of the performance award indicates that certain performance targets were not fully met, which could be viewed neutrally or slightly negatively depending on the specific targets.
• Employees: The compensation structure for a key executive provides insight into the company's overall approach to executive incentives and retention.

Next Steps

• One-third of the 24,270 Restricted Stock Equivalents will vest on November 14, 2026, 2027, and 2028, subject to employment conditions.

Key Dates

Recommendation

This Form 4 details routine executive compensation transactions, including the vesting of performance-based equity and the grant of new restricted stock. While a portion of the performance award did not vest, this is a standard mechanism for incentive alignment and does not, on its own, provide sufficient new information to alter a fundamental investment thesis. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Edgewell Personal Care, EPC, Form 4, Insider Transaction, Stock Vesting, Restricted Stock, Performance Stock, Executive Compensation, LaTanya Langley